Aspects of the Pharmaceutical Business Model: Implications for Australia

[img]
wp15_2003_rasmussen.PDF - Draft Version (66kB)

Rasmussen, Bruce ORCID: 0000-0001-5779-0339 (2003) Aspects of the Pharmaceutical Business Model: Implications for Australia. Working Paper. Victoria University, Melbourne, Australia.

Abstract

The business model of the large pharmaceutical companies is complex and has become increasingly so with the technological developments in the industry particularly in relation to the innovations introduced by biotechnology. A business model is not a well defined concept but may be paraphrased as a description of 'how a business makes its money'. It answers a series of questions essential to any business - who are the customers, what do they value, what is the underlying economic logic that explains how that value can be delivered to the customer at an appropriate cost and finally how the business makes its money. It consists of both a narrative of how the business works and the numbers - how it makes a profit (Margretta 2002). Underlying any business model is the structure of its value chain.

Dimensions Badge

Altmetric Badge

Item type Monograph (Working Paper)
URI https://vuir.vu.edu.au/id/eprint/102
DOI 15
Subjects Historical > RFCD Classification > 320000 Medical and Health Sciences
Historical > FOR Classification > 1115 Pharmacology and Pharmaceutical Sciences
Historical > Faculty/School/Research Centre/Department > Centre for Strategic Economic Studies (CSES)
Keywords pharmaceutical business model; pharmaceutical industry; Australia; stress
Download/View statistics View download statistics for this item

Search Google Scholar

Repository staff login